Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the ...
To systematically end active awards is a departure for NIH, which has terminated grants to Duke, UNC and RTI International.
Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus", "SLP"), a leading provider of cheminformatics, biosimulation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback